The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > Faeces analyses

Faeces analysis

Simple and rapid method for assessing your compound’s direct impact on intestinal lipid absorption in obesity and/or dyslipidemia.

This method can be used both for medium scale screening purposes and for initial in vivo proof-of-concept.

key benefits

  • Robust in vivo validation on intestinal lipid absorption.
  • Large-scale screening with a rapid and reproducible in vivo technique.

description and parameters

Species

  • Rat
  • Mouse

Parameters evaluated

  • Neutral lipids : phytosterol, diglycerides, cholesterol ester, triglycerides
  • Fatty acids: SAFA, MUFA, PUFA

Fecal lipids analysis
Fecal lipids analysis

Add-on studies